GoKawiil
AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth
(feeds.content.dowjones.io)
1.
2.
How AI helps scientists design the next generation of medicines
(technologyreview.com)
3.
AstraZeneca Enters Exclusive License Deal for Lung Cancer Drug Zegfrovy for Up to $1.5 Billion
(feeds.content.dowjones.io)
4.
AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion
(feeds.content.dowjones.io)
5.
Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens GSK Partnership
(feeds.content.dowjones.io)
6.
AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal
(feeds.content.dowjones.io)
7.
AstraZeneca Confident Rare-Disease Drug Can Hit Target After Mixed Study Results
(feeds.content.dowjones.io)
8.
AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer
(feeds.content.dowjones.io)
9.
How some COVID vaccines triggered rare blood-clot disorder
(feeds.nature.com)
10.
Now You Can Get Your Flu Vaccine at Home
(wired.com)